130306-02-4Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)/C2=C\F)c(=O)n1GFFXZLZWLOBBLO-ASKVSEFXSA-NTezacitabine is a hydroxypyrimidine.
130306-02-4、171176-43-5DTXSID10156446CHEMBL2105467、CHEMBL3989496CHEBI:230773Phosphorylated by cellular kinases, tezacitabine is converted into its active diphosphate and triphosphate metabolites. Tezacitabine diphosphate binds to and irreversibly inhibits the activity of the enzyme ribonucleotide reductase (RNR), which may result in the inhibition of DNA synthesis in tumor cells and tumor cell apoptosis. Tezacitabine triphosphate acts as a substrate for DNA polymerase, further compromising DNA replication. This agent is relatively resistant to metabolic deactivation by cytidine deaminase. RNR catalyzes the conversion of ribonucleoside 5'-diphosphates to deoxyribonucleoside 5'-diphosphates necessary for DNA synthesis and is overexpressed in many tumor types.
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells.
VerwendenTezacitabine is used in the synthesis of inhibitors of ribonucleoside diphosphate reductase.